Last Update 06 Jun 26
Fair value Increased 0.82%LIN: Pricing Power And Capital Returns Will Support Fairly Valued Helium And Hydrogen Exposure
Linde's analyst price target has been raised by around $4 to $545, with analysts pointing to updated assumptions around fair value, discount rate, revenue growth, profit margins, and future P/E as support for the move.
Analyst Commentary
Recent Street research around Linde has centered on a series of price target revisions and one rating upgrade, giving you a clearer sense of how professionals are thinking about valuation, execution risk, and growth opportunities.
Bullish Takeaways
- Bullish analysts have raised price targets in a wide range, from single digit dollar moves to larger increases of $25, $35, $40, and $50, which signals growing conviction in the stock's potential value relative to prior assumptions.
- The upgrade to Overweight at JPMorgan, alongside a price target change to $525 from $455, points to a view that Linde is better positioned for current market conditions than many materials companies, particularly given its customer mix.
- JPMorgan highlights that U.S. chemical customers may run plants harder to capture higher export prices. If this occurs, it could support Linde's volumes and pricing power and help justify higher valuation multiples.
- Mizuho's move to a US$560 target, with commentary that easing Middle East related pressure on the helium market is supportive, indicates confidence that some supply constraints are less of a drag on future earnings assumptions.
Bearish Takeaways
- Several price target changes, including smaller moves of $4, $5, and $15, suggest some analysts are adjusting models rather than making wholesale upgrades. This can point to a more cautious stance on how much upside remains from current levels.
- Despite the JPMorgan upgrade, not all research items mention rating changes. This implies some firms may see Linde as fairly valued and are tweaking price targets mainly to reflect updated inputs such as discount rates or helium market conditions.
- The repeated focus on assumptions such as future P/E, profit margins, and discount rates underscores that a meaningful part of the bullish case rests on modeling choices. These could be sensitive to shifts in macro conditions or end market demand.
- The range between higher price targets like US$560 and lower ones in the low US$500s highlights dispersion in views. This is a reminder that execution on projects and customer demand trends will be key to justifying the more optimistic scenarios.
What's in the News
- Linde has received broad analyst upgrades with a Strong Buy consensus and raised price targets, with a reported average around US$553 and some as high as US$580, citing durable, inflation linked cash flows and margin expansion following the Praxair merger. (Source: "Linde plc Receives Broad Analyst Upgrades with Strong Buy Consensus and Raised Price Targets")
- Recent research highlights Linde's exposure to electronics, healthcare, and clean energy projects, including carbon capture and hydrogen production, alongside AI driven efficiency efforts and cost controls. (Source: "Linde plc Receives Broad Analyst Upgrades with Strong Buy Consensus and Raised Price Targets")
- Linde reported stronger than expected Q1 2026 earnings and revenue and raised the lower end of its full year earnings guidance and Q2 adjusted EPS outlook, supported by a reported adjusted operating margin of 30.0% and a US$7.1b gas project backlog. (Source: "Linde Raises 2026 Outlook as Analysts Boost Price Targets on Strong Q1 Results and Growth Prospects")
- Growth drivers flagged in recent coverage include demand in U.S. refining, electronics, manufacturing, commercial space, hydrogen, helium, and other industrial gas markets, along with Linde's role in the Woodside low carbon hydrogen and nitrogen supply project expected to start up by 2027. (Source: "Linde Raises 2026 Outlook as Analysts Boost Price Targets on Strong Q1 Results and Growth Prospects")
- Linde announced new air separation units in Garysburg, North Carolina and Oshkosh, Wisconsin, each planned to produce liquid oxygen, nitrogen, and argon for regional customers, with both plants expected to start up in 2028. (Source: Key Developments)
Valuation Changes
- Fair Value has risen slightly to $545.04 from $540.61, a move of about 0.8% that aligns with the latest analyst target increase.
- Discount Rate has fallen slightly to 7.85% from 7.91%, which increases the present value of projected cash flows in updated models.
- Revenue Growth has edged higher to 5.78% from 5.66%, reflecting modestly stronger long term sales assumptions in analyst forecasts.
- Net Profit Margin has moved up slightly to 23.06% from 22.94%, indicating a small adjustment toward higher expected profitability on each $ of revenue.
- Future P/E has risen slightly to 32.09x from 31.65x, signaling a modestly higher valuation multiple applied to projected earnings.
Key Takeaways
- Expansion in clean energy, electronics, and emerging markets positions Linde for sustained growth and structurally higher margins through strategic investments and long-term contracts.
- Focus on digitalization, operational efficiency, and decarbonization trends drives margin improvement, resilient cash flow, and benefits from global regulatory support.
- Structural risks from weak industrial demand, oversupply pressures, and an uncertain energy transition threaten Linde's revenue growth, pricing power, and long-term profitability.
Catalysts
About Linde- Operates as an industrial gas company in the United States, China, Germany, the United Kingdom, Australia, Mexico, Brazil, and internationally.
- Linde's project backlog has doubled over the last 4 years-anchored by long-term, fixed-fee contracts supporting U.S. clean energy and electronics infrastructure-and management expects this robust pipeline to remain at record levels, positioning the company for steady multi-year revenue and earnings growth.
- Strategic investments and customer commitments in rapidly expanding growth markets such as commercial space launches, electronics, and clean hydrogen (with almost $5 billion in new clean energy contracts) provide a runway for high-margin revenue streams and new project conversion that will structurally lift blended margins and earnings.
- Linde's ongoing focus on digitalization, operational optimization, and network density-including base volume growth CapEx and bolt-on M&A-should continue to drive self-help margin improvement and support strong operating cash flow and net margin expansion, even through cyclical downturns.
- Structural tailwinds from the global push for decarbonization, demand for low-carbon hydrogen/ammonia, and ongoing regulatory/incentive support (e.g., enhanced tax credits like 45Q and bonus depreciation in the U.S.) are expected to accelerate both revenue and project IRRs for years as energy transition investments continue.
- The increasing need for medical and specialty gases in emerging markets (notably APAC and India), coupled with an aging global population and higher healthcare standards, supports long-term, stable growth in high-value segments and underpins future recurring revenue and cash flow stability.
Linde Future Earnings and Revenue Growth
Assumptions
How have these above catalysts been quantified?
- Analysts are assuming Linde's revenue will grow by 5.8% annually over the next 3 years.
- Analysts assume that profit margins will increase from 20.4% today to 23.1% in 3 years time.
- Analysts expect earnings to reach $9.5 billion (and earnings per share of $21.23) by about June 2029, up from $7.1 billion today. However, there is some disagreement amongst the analysts with the more bullish ones expecting earnings as high as $10.6 billion.
- In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 32.1x on those 2029 earnings, down from 33.2x today. This future PE is greater than the current PE for the US Chemicals industry at 27.8x.
- Analysts expect the number of shares outstanding to decline by 1.35% per year for the next 3 years.
- To value all of this in today's terms, we will use a discount rate of 7.85%, as per the Simply Wall St company report.
Risks
What could happen that would invalidate this narrative?- Persistent deindustrialization and economic weakness in Europe, including potential chemical and manufacturing plant closures, present a long-term structural risk for Linde, which could lead to sustained volume declines and revenue contraction in the region and erode network density, impacting profitability.
- Ongoing global economic uncertainty and weak industrial activity in key markets, especially in Europe and parts of Asia-Pacific, heighten the risk of prolonged or worsening negative base volume growth, which may suppress revenue and EPS growth if industrial recovery remains slow.
- Oversupply and price pressures in certain product lines (e.g., helium in China and Asia), as well as evolving competition from regional players or new market entrants in commoditized gases, could create downward pressure on pricing and net margins, reducing overall profitability.
- Despite a robust low-carbon project backlog, the energy transition in Europe and globally may progress slower than anticipated due to regulatory delays, pragmatism over targets, and long permitting/infrastructure timelines; this uncertainty about the pace of clean energy adoption could hinder long-term sales growth from new projects and impact returns on invested capital.
- Large, long-term contracts-especially for on-site supply in cyclical or declining industries-can insulate near-term earnings but pose a risk of future revenue volatility and margin compression if structural demand for gases weakens in core end markets (steel, refining, chemicals), or if customers fall below minimum take-or-pay thresholds over time.
Valuation
How have all the factors above been brought together to estimate a fair value?
- The analysts have a consensus price target of $545.04 for Linde based on their expectations of its future earnings growth, profit margins and other risk factors.
- However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $600.0, and the most bearish reporting a price target of just $400.0.
- In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be $41.0 billion, earnings will come to $9.5 billion, and it would be trading on a PE ratio of 32.1x, assuming you use a discount rate of 7.9%.
- Given the current share price of $507.9, the analyst price target of $545.04 is 6.8% higher. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
- We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.
Have other thoughts on Linde?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeHow well do narratives help inform your perspective?
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.